Prognostic Significance of the Stage at Which an MRD-Negative Status Is Achieved for Patients With Multiple Myeloma Who Received ASCT

ObjectiveTo explore the prognostic significance of the stage at which a minimal residual disease (MRD)-negative status is achieved for patients with newly diagnosed multiple myeloma (NDMM) who received autologous hematopoietic stem cell transplantation (ASCT).Cases and MethodsA retrospective analysi...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Qian Sun, Xiaozhe Li, Jingli Gu, Beihui Huang, Junru Liu, Meilan Chen, Juan Li
Médium: Artigo
Jazyk:Inglês
Vydáno: Frontiers Media S.A. 2022-05-01
Edice:Frontiers in Oncology
Témata:
autologous stem cell transplantation
minimal residual disease
multiple myeloma
overall survival
time to progression
On-line přístup:https://www.frontiersin.org/articles/10.3389/fonc.2022.776920/full
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky